Roche’s Brainshuttle technology promises next generation of amyloid beta mAbs, says GlobalData Read more
CNS market to surpass $80 bn in 2025, driven by MS and psychiatric drug innovation: GlobalData Read more
NICE rejects second Alzheimer’s drug but opportunity remains for decision change: GlobalData Read more
PharmaKure’s novel blood test can identify biomarkers in patients with Alzheimer’s Disease: Study Read more
Researchers from Tel Aviv University develop process that could reverse early signs of Alzheimer’s Read more
